IGC Pharma: Ascendiant Capital Maintains Buy Rating, Raises PT to $5.

Monday, Feb 23, 2026 5:08 am ET1min read
IGC--

IGC Pharma: Ascendiant Capital Maintains Buy Rating, Raises PT to $5.

IGC Pharma: Ascendiant Capital Maintains Buy Rating, Raises PT to $5.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet